Malmgren C, Wagner E G, Ehresmann C, Ehresmann B, Romby P
Department of Microbiology, Biomedical Center, Uppsala University, Box 581 S-751 23 Uppsala, Sweden.
J Biol Chem. 1997 May 9;272(19):12508-12. doi: 10.1074/jbc.272.19.12508.
The replication frequency of plasmid R1 is controlled by an antisense RNA (CopA) that binds to its target site (CopT) in the leader region of repA mRNA and inhibits the synthesis of the replication initiator protein RepA. Previous studies on CopA-CopT pairing in vitro revealed the existence of a primary loop-loop interaction (kissing complex) that is subsequently converted to an almost irreversible duplex. However, the structure of more stable binding intermediates that lead to the formation of a complete duplex was speculative. Here, we investigated the interaction between CopA and CopT by using Pb(II)-induced cleavages. The kissing complex was studied using a truncated antisense RNA (CopI) that is unable to form a full duplex with CopT. Furthermore, RNase III, which is known to process the CopA-CopT complex in vivo, was used to detect the existence of a full duplex. Our data indicate that the formation of a full CopA-CopT duplex appears to be a very slow process in vitro. Unexpectedly, we found that the loop-loop interaction persists in the predominant CopA-CopT complex and is stabilized by intermolecular base pairing involving the 5'-proximal 30 nucleotides of CopA and the complementary region of CopT. This almost irreversible complex suffices to inhibit ribosome binding at the tap ribosome binding site and may be the inhibitory complex in vivo.
质粒R1的复制频率受一种反义RNA(CopA)控制,CopA与其靶位点(CopT)结合,该靶位点位于repA mRNA的前导区,抑制复制起始蛋白RepA的合成。先前对CopA - CopT体外配对的研究揭示了一种初级环 - 环相互作用(亲吻复合体)的存在,这种相互作用随后会转变为几乎不可逆的双链体。然而,导致形成完整双链体的更稳定结合中间体的结构只是推测性的。在此,我们利用铅(II)诱导的切割研究了CopA与CopT之间的相互作用。使用一种截短的反义RNA(CopI)来研究亲吻复合体,CopI无法与CopT形成完整的双链体。此外,已知在体内加工CopA - CopT复合体的核糖核酸酶III被用于检测完整双链体的存在。我们的数据表明,在体外形成完整的CopA - CopT双链体似乎是一个非常缓慢的过程。出乎意料的是,我们发现环 - 环相互作用在主要的CopA - CopT复合体中持续存在,并通过涉及CopA 5'端近端30个核苷酸和CopT互补区域的分子间碱基配对而稳定。这种几乎不可逆的复合体足以抑制核糖体在tap核糖体结合位点的结合,可能是体内的抑制性复合体。